DrugPatentWatch Database Preview
Emd Serono Company Profile
What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?
EMD SERONO has thirteen approved drugs.
There are five US patents protecting EMD SERONO drugs.
Summary for Emd Serono
| US Patents: | 5 |
| Tradenames: | 13 |
| Ingredients: | 8 |
| NDAs: | 13 |
Drugs and US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 020378-003 | May 25, 2000 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-003 | Mar 25, 2004 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Emd Serono | ZORBTIVE | somatropin recombinant | INJECTABLE;INJECTION | 021597-004 | Dec 1, 2003 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Emd Serono | GONAL-F RFF | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-002 | Mar 25, 2004 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-001 | May 25, 2004 | RX | Yes | Yes | 7,741,268 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Emd Serono | NOVANTRONE | mitoxantrone hydrochloride | INJECTABLE;INJECTION | 019297-001 | Dec 23, 1987 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono | NOVANTRONE | mitoxantrone hydrochloride | INJECTABLE;INJECTION | 019297-001 | Dec 23, 1987 | 4,820,738 | ➤ Sign Up |
| Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-001 | Sep 26, 1997 | 4,517,181 | ➤ Sign Up |
| Emd Serono | GONAL-F RFF | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-002 | Mar 25, 2004 | 5,767,067 | ➤ Sign Up |
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 020378-002 | Sep 29, 1997 | 4,589,402 | ➤ Sign Up |
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-003 | Mar 25, 2004 | 5,767,251 | ➤ Sign Up |
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-002 | May 25, 2004 | 5,767,251 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Emd Serono Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Israel | 139027 | ➤ Sign Up |
| Norway | 326406 | ➤ Sign Up |
| Indonesia | 28747 | ➤ Sign Up |
| Hungary | 228736 | ➤ Sign Up |
| Hong Kong | 1086503 | ➤ Sign Up |
| European Patent Office | 0814841 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Emd Serono Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 9C0031 | Belgium | ➤ Sign Up | PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413 |
| 01C/020 | Belgium | ➤ Sign Up | PRODUCT NAME: LUTROPINE ALFA; REGISTRATION NO/DATE: EU/1/00/155/001 20001129 |
| /1999 | Austria | ➤ Sign Up | PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413 |
| 00440 | Netherlands | ➤ Sign Up | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125; FORMER OWNER: N.V. ORGANON, NL |
| C/GB10/022 | United Kingdom | ➤ Sign Up | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125 |
| 2010000011 | Germany | ➤ Sign Up | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
